Molecular evidence supporting field effect in urothelial carcinogenesis.
about
Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progressionHypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer.Laser capture microdissection in the genomic and proteomic era: targeting the genetic basis of cancer.Clonal origin of multifocal hepatocellular carcinoma.The origins of urothelial carcinoma.Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers.Staging and reporting of urothelial carcinoma of the urinary bladder.Urinary protein biomarker panel for the detection of recurrent bladder cancerExpression of claudins and their prognostic significance in noninvasive urothelial neoplasms of the human urinary bladder.Prognostic Significance of CREB-Binding Protein and CD81 Expression in Primary High Grade Non-Muscle Invasive Bladder Cancer: Identification of Novel Biomarkers for Bladder Cancer Using Antibody Microarray.Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression.Claudins and ki-67: potential markers to differentiate low- and high-grade transitional cell carcinomas of the urinary bladderImmunohistochemistry and Fluorescence In Situ Hybridization Can Inform the Differential Diagnosis of Low-Grade Noninvasive Urothelial Carcinoma with an Inverted Growth Pattern and Inverted Urothelial Papilloma.Determining the origin of synchronous multifocal bladder cancer by exome sequencing.Melanoma cells undergo aggressive coalescence in a 3D Matrigel model that is repressed by anti-CD44.The role of chemotherapy in upper tract urothelial carcinoma.Comparison of the clonality of urothelial carcinoma developing in the upper urinary tract and those developing in the bladder.Bladder cancer: clinical and pathological profile.Molecular determinants of tumor recurrence in the urinary bladder.Evaluation of zinc finger E-box binding homeobox 1 and transforming growth factor-beta2 expression in bladder cancer tissue in comparison with healthy adjacent tissue.Urothelial cancers: using biology to improve outcomes.Tissue engineering for the oncologic urinary bladder.Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours.The relationship of cancer stem cells in urological cancers.Biophysical characterization of bladder cancer cells with different metastatic potential.Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours.Mediated coalescence: a possible mechanism for tumor cellular heterogeneity.Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation.Using the epigenetic field defect to detect prostate cancer in biopsy negative patients.Anatomical location of urothelial carcinomas of the urinary tract leads to perspectives of specific treatment.Bladder Cancer: New Insights into Its Molecular Pathology.Evaluation of Intraoperative Versus Postoperative Adjuvant Mitomycin C with Nephroureterectomy for Urothelial Carcinoma of the Upper Urinary Tract
P2860
Q26852716-A822681A-2C39-44BE-A7C4-2258ADD9DCA5Q30981767-786B6E71-D98F-4698-A2E3-51999B0E8F28Q33369059-0ED9FE7D-705F-47EB-981B-9A7718CED9D1Q33610269-B8380571-4A88-4BBD-BD88-23C23DD4E1A8Q34121078-A20650A3-081F-4874-B85D-CAE40BD60C74Q34788410-9D09A55A-6639-4D8D-9676-EAF0178BB117Q34984796-8C51E11D-6878-41C5-9F59-2E0D0127082AQ35050119-73C8195E-3B19-4F13-BFA5-22321C55C866Q35440688-7A79EA89-75F3-4D15-A125-18CACBBF97A2Q35542497-181E97CD-FE27-49E0-870F-A1CEC6AA4AC9Q35644340-6D14DAB4-3484-4826-940C-71176291F317Q35681850-D8CD2E57-AFF0-4198-BE54-F75542D5C7CFQ35712039-31B87F7B-D1C2-425B-BF3E-FE5439549C67Q35836678-0BEC044F-7D64-4280-8251-8D59704ABD79Q36298393-6C4D961A-9BF4-4DB5-9234-AB5310A4789FQ37071515-FAD98777-B4DF-430B-87AA-8A5034998F17Q37152820-CA21F33D-EC3A-42C0-829E-AAC6B34DDB88Q37278983-19A98F79-4CB4-406B-8926-303F404EDD51Q37575626-853A60F6-6C92-48B4-A305-18C0C6458C4DQ37671699-4B65E89C-B1C1-422C-B76B-6E48AAB36E52Q37965638-EC39E4FF-04C0-4341-87F8-82787DFC0A8BQ38036123-884F6903-312C-49A8-B6EF-9A259639C5D6Q38044251-425D6695-0FFB-480B-9CFA-CD8017C10C11Q38202644-18F7D6AD-909E-4802-949A-7E97CF09F13DQ39136134-EEA34D97-BF92-4F44-BEBE-870C0D8D3419Q39169405-C728FCCE-2AB1-4552-BA7B-3B7B74EB06A6Q41428961-0F71359D-E04F-4019-93CD-435CF896A6B0Q42105949-85387CBC-98D3-40D6-B36F-524D062DC9E7Q42558314-6F52194C-D2A4-414C-9D7C-D9F9B76FA38FQ43709798-2FC2BB5A-98F8-4748-9E0F-76EE3E1483CEQ52609673-3ED4166B-9073-43D3-9E27-70397CB369D9Q58705116-9D8C3C4B-3D6F-4552-8BDF-D8592C968212
P2860
Molecular evidence supporting field effect in urothelial carcinogenesis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Molecular evidence supporting field effect in urothelial carcinogenesis.
@ast
Molecular evidence supporting field effect in urothelial carcinogenesis.
@en
type
label
Molecular evidence supporting field effect in urothelial carcinogenesis.
@ast
Molecular evidence supporting field effect in urothelial carcinogenesis.
@en
prefLabel
Molecular evidence supporting field effect in urothelial carcinogenesis.
@ast
Molecular evidence supporting field effect in urothelial carcinogenesis.
@en
P2093
P1476
Molecular evidence supporting field effect in urothelial carcinogenesis.
@en
P2093
Antonio Lopez-Beltran
Gregory T MacLennan
John N Eble
Liang Cheng
Mingsheng Wang
Shaobo Zhang
Timothy D Jones
P304
P356
10.1158/1078-0432.CCR-05-0891
P407
P577
2005-09-01T00:00:00Z